Usually, in cancer cells, the activity of CDK-cyclin complexes is deregulated, thereby resulting in uncontrolled cell growth owing to increased Rb phosphorylation (Rb inactivation) and transcriptional activity (78, 79). This evidence concerns the gene RB1 and cancer.